APOLLO ENDOSURGERY INC (APEN) Stock Price & Overview
NASDAQ:APEN • US03767D1081
Current stock price
The current stock price of APEN is 10 USD. Today APEN is up by 0.81%. In the past month the price increased by 0.5%. In the past year, price increased by 65.56%.
APEN Key Statistics
- Market Cap
- 475.492M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.98
- Dividend Yield
- N/A
APEN Stock Performance
APEN Stock Chart
APEN Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to APEN. When comparing the yearly performance of all stocks, APEN is one of the better performing stocks in the market, outperforming 96.28% of all stocks.
APEN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to APEN. APEN may be in some trouble as it scores bad on both profitability and health.
APEN Earnings
APEN Forecast & Estimates
11 analysts have analysed APEN and the average price target is 10.2 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 10.
For the next year, analysts expect an EPS growth of 13.1% and a revenue growth 18.29% for APEN
APEN Groups
Sector & Classification
APEN Financial Highlights
Over the last trailing twelve months APEN reported a non-GAAP Earnings per Share(EPS) of -0.98. The EPS decreased by -9.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 1.04 |
APEN Ownership
APEN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.91 | 178.754B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.23 | 160.562B | ||
| SYK | STRYKER CORP | 21.92 | 126.877B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.96 | 93.218B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.9 | 47.074B | ||
| IDXX | IDEXX LABORATORIES INC | 38.42 | 45.348B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 43.995B | ||
| RMD | RESMED INC | 18.25 | 32.645B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.062B | ||
| DXCM | DEXCOM INC | 24.47 | 23.946B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.783B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.888B | ||
| PODD | INSULET CORP | 31.6 | 14.383B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About APEN
Company Profile
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. The company is headquartered in West Lake Hills, Texas and currently employs 107 full-time employees. The company went IPO on 2005-04-21. The firm develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The firm's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.
Company Info
IPO: 2005-04-21
APOLLO ENDOSURGERY INC
1120 S Capital of Texas Hwy Bldg 1 Ste 300
West Lake Hills TEXAS 78746 US
CEO: Todd Newton
Employees: 107
Phone: 15122795100.0
APOLLO ENDOSURGERY INC / APEN FAQ
Can you describe the business of APOLLO ENDOSURGERY INC?
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. The company is headquartered in West Lake Hills, Texas and currently employs 107 full-time employees. The company went IPO on 2005-04-21. The firm develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The firm's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.
What is the stock price of APOLLO ENDOSURGERY INC today?
The current stock price of APEN is 10 USD. The price increased by 0.81% in the last trading session.
Does APEN stock pay dividends?
APEN does not pay a dividend.
What is the ChartMill technical and fundamental rating of APEN stock?
APEN has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is APOLLO ENDOSURGERY INC (APEN) stock traded?
APEN stock is listed on the Nasdaq exchange.
What do analysts say about APOLLO ENDOSURGERY INC (APEN) stock?
11 analysts have analysed APEN and the average price target is 10.2 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 10.
What is the GICS sector and industry of APEN stock?
APOLLO ENDOSURGERY INC (APEN) operates in the Health Care sector and the Health Care Equipment & Supplies industry.